Using our extensive experience and industry knowledge we aim to provide thought leadership in the companies we cover. Our Independent Research model means we ‘live and die’ by the quality of our research. As Global Pharmaceutical output continues to soar driven by new technologies drawn from the broader Healthcare space, we believe there is the need for a dedicated European Healthcare Boutique to help investors identify new opportunities and piece together the increasingly complex landscape. We have written extensively, highlighting that the sector is entering an R&D SuperCycle which will last well into the next decade. We aim to help investors benefit from this trend by identifying companies with structural growth that will ride high on this extended innovation wave.